Nodexus

Nodexus NX One - Affordable Benchtop Cell Sorting <$100K

San Francisco, United States · Founded 2014 · $31.8M raised

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$31.8M
Last Round
$30.0M Series ADec 2021
Rounds
3

About

Nodexus is a UC Berkeley/Stanford StartX-backed biotech company commercializing single-cell sorting and dispensing technology for gene editing, drug development, and biological research. Its NX One instrument provides affordable, benchtop single-cell sorting starting under $100K.

Summary

Nodexus is a Healthcare company based in San Francisco, United States, founded in 2014. It has raised $31.8M in total across 3 rounds, most recently a $30.0M Series A round in Dec 2021. Investors include RA Capital Management and Section 32.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ADec 2021
$30.0M

Sign up to see all 3 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nodexus on Indexed.vc
<a href="https://indexed.vc/companies/nodexus"><img src="https://indexed.vc/api/badge/company/nodexus" alt="Nodexus on Indexed.vc" width="260" height="76" /></a>